Archive Archives – Page 7 of 7

Messages to the Chancellor from VC Backed Companies

19th March 2013

Many of the companies that Midven works with are creating exciting products with international reach, but they are looking for more help in accessing and selling to these markets.

Midven Annual Review 2013

18th February 2013

Midven Annual Review 2013

Funding For Growth – An Insight From The Coalface

17th January 2013

The path of raising finance for the entrepreneur is always a precarious balancing act.

Crescendo Biologics Announces Breakthrough Technology Progress

17th January 2013

Cambridge, UK. 16th January 2013 – Crescendo Biologics Limited (Crescendo) today announces the Crescendo Mouse, a breakthrough in antibody fragment technology.

Business Awards – Are They of Any Value?

3rd December 2012

Hot on the heels of yet another Midven portfolio company securing an award the burning question has to be – is applying for, and winning, business awards of any value to your business?

MoD Spin-Out Receives Funding For Technology That Promises Improved Earlier Detection And Treatment of Cancer

29th November 2012

ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl), today announces a £482k award.

Why Venture Capital is the Right Long Term Funding Partner for Growing Businesses

18th September 2012

Everywhere you look at the moment is risk, whether it be political, economic or financial, particular in relation to the ongoing travails within the EU.

Aitua Enters Into Option Agreement With Nicox To Acquire Altacor

16th March 2012

NicOx enters into option agreement to acquire Altacor as a first step towards building an international ophthalmology business.

Cobalt Light Systems Receives European Approval For It’s Bottle Scanner

7th January 2012

Cobalt Light Systems has received European approval for its revolutionary INSIGHT100 bottle scanner, which enables aircraft passengers to carry liquid items larger than 100ml once more.

New Antibiotic Compound Enters Phase 1 Clinical Trial

8th November 2011

Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase 1 clinical trial of a new antibiotic to treat the hospital superbug Clostridium difficile.

P2i Demonstrates Magical Protective Liquid Repellent Nano-Coating For Smartphones At IFA 2011

8th October 2011

Just one drop of liquid can destroy your phone or tablet! Acting like a barrier, Splash-Guard protects your XOOM 2 & XOOM 2 Media Edition from those unexpected spills and splashes.

Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

8th June 2011

Cambridge, UK. 22 June 2011 – Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer.

Mike Romanos Appointed CEO Of Crescendo Biologics

8th February 2011

UK. 12 October 2009 – Mike Romanos has been appointed Chief Scientific Officer of Crescendo Biologics (“Crescendo”) and joins the Board as a Director.

Latest Insights, Interviews, News, and Resources.

Messages to the Chancellor from VC Backed Companies

Midven Annual Review 2013

Funding For Growth – An Insight From The Coalface

Crescendo Biologics Announces Breakthrough Technology Progress

Business Awards – Are They of Any Value?

MoD Spin-Out Receives Funding For Technology That Promises Improved Earlier Detection And Treatment of Cancer

Why Venture Capital is the Right Long Term Funding Partner for Growing Businesses

Aitua Enters Into Option Agreement With Nicox To Acquire Altacor

Cobalt Light Systems Receives European Approval For It’s Bottle Scanner

New Antibiotic Compound Enters Phase 1 Clinical Trial

P2i Demonstrates Magical Protective Liquid Repellent Nano-Coating For Smartphones At IFA 2011

Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

Mike Romanos Appointed CEO Of Crescendo Biologics

Stay updated